Note AcademyNote Academy

Biology · Oct / Nov 2022 · Paper 41 · Question 6

YBI11

As printed in the paper

The question as text

6 Alzheimer’s disease is a cause of dementia in older people. The neurones in the brain are damaged and eventually destroyed. Abnormal plaques are seen in the brains of people with Alzheimer’s disease. These plaques are made of a protein called ß‑amyloid. Drug ATD is a new drug used to treat people with Alzheimer’s disease. This drug is an antibody that is specific for ß‑amyloid.

Read automatically from the paper; the printed page above is exact.

Show the answer and mark scheme
  • 6(a)[3]

    A description that includes three of the following points:

    whether it caused side effects (in humans) (1)

    ACCEPT named side effect e.g. allergic

    reaction

    ACCEPT {plaque / amyloid} disappeared

    whether or not it reduced the size of the plaques (1)

    better than existing drugs

    effective

    ACCEPT dose

    {(an effective) concentration / the half life} of the drug (1)

    the (best) method to administer the drug (1)

    how long to administer drug (for amyloid to be destroyed) (1)

  • 6(b)(i)[2]

    An explanation that includes the following points:

    antibodies can only bind to their antigen / this antibody can only

    bind to β amyloid (1)

    ACCEPT FAB region / FAB receptor /

    because of the (complementary) shape of {antigen / antibody} (1)

    receptor

  • 6(b)(ii)[3]

    An answer that includes the following points:

    {ATD / antibodies} will bind to the amyloid (1)

    ACCEPT opsonisation

    macrophages engulf the amyloid (1)

    ACCEPT phagocytes / neutrophils

    ACCEPT phagocytes / neutrophils

    macrophages {destroy / digest} the amyloid with {enzymes /

    lysozymes} (1)

    protease

    DO NOT ACCEPT lysosome

  • 6(c)(i)[2]

    An answer that includes the following points:

    because their immune system had already been activated

    ACCEPT a description e.g. a primary

    (against amyloid) (1)

    immune response had already taken

    place, the person had memory cells (to

    amyloid)

    antibodies present

    and therefore {the amyloid was broken down / plaques could not

    DO NOT ACCEPT by antibodies / B cells

    form} (by phagocytes) (1)

  • 6(c)(ii)[2]

    An explanation that includes the following points:

    because people with Alzheimer’s disease will not have these

    ACCEPT B memory cells not effective

    memory cells (1)

    and therefore there will not be any memory cells that can

    ACCEPT no memory cells that will

    differentiate into the plasma cells that produce the antibody (1)

    result in the production of antibody

    DO NOT ACCEPT no memory cells to

    produce the antibody

Make a free account to save your answers and see your weak topics and ask the AI why a wrong answer is wrong.